FDA Approved: OFEV — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved OFEV (nintedanib) as the original application for the treatment of idiopathic pulmonary fibrosis. This marked the initial regulatory authorizat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• OFEV (Nintedanib)

Snippet

ORIG AP for OFEV (NINTEDANIB)